Francesca Palandri

Francesca Palandri

UNVERIFIED PROFILE

Are you Francesca Palandri?   Register this Author

Register author
Francesca Palandri

Francesca Palandri

Publications by authors named "Francesca Palandri"

Are you Francesca Palandri?   Register this Author

97Publications

2149Reads

42Profile Views

The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based review.

Bone Marrow Transplant 2019 Sep 18. Epub 2019 Sep 18.

Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0683-1DOI Listing
September 2019

Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis.

Br J Haematol 2019 Jun 18;185(5):987-991. Epub 2018 Nov 18.

Institute of Haematology "L. e A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15682DOI Listing
June 2019

Treating early-stage myelofibrosis.

Ann Hematol 2019 Feb 20;98(2):241-253. Epub 2018 Oct 20.

Division of Hematology, Department of Internal Medicine, University Hospital Ospedale di Circolo e Fondazione Macchi, ASST dei Sette Laghi, Varese, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3526-zDOI Listing
February 2019

Understanding how older age drives decision-making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients.

Br J Haematol 2019 Feb 8;184(3):424-430. Epub 2018 Nov 8.

Institute of Haematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.15668
Publisher Site
http://dx.doi.org/10.1111/bjh.15668DOI Listing
February 2019

Mutations in and genes are associated with specific alterations of the immune system in myelofibrosis.

Oncoimmunology 2017 5;6(10):e1345402. Epub 2017 Jul 5.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1345402DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665081PMC
July 2017

New strategies in myelofibrosis: the evolving paradigm of disease pathogenesis, prognostication and treatment.

Hematol Oncol 2017 Jun 10;35(2):145-150. Epub 2016 Aug 10.

Department of Hematology and Oncology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Via Massarenti 9, 40138, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2324DOI Listing
June 2017

The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study.

Oncotarget 2017 Jun;8(23):37239-37249

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology 'L. and A. Seràgnoli', University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.16744DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514906PMC
June 2017

Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response.

Eur J Haematol 2017 Apr 20;98(4):371-377. Epub 2017 Jan 20.

Department of Hematology, Azienda Sanitaria Universitaria Integrata S. Maria della Misericordia, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12839DOI Listing
April 2017

Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients.

Am J Hematol 2017 Jan 12;92(1):37-41. Epub 2016 Nov 12.

Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Institute of Hematology and Clinical Oncology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24572DOI Listing
January 2017

Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and Splenomegaly.

Mediators Inflamm 2016;2016:5860657. Epub 2016 Sep 8.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/5860657DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031875PMC
September 2016

Low-dose methotrexate as treatment of myeloproliferative neoplasms: Proof of principle of clinical activity.

Am J Hematol 2016 08 3;91(8):E329-30. Epub 2016 Jun 3.

Division of Hematology, Azienda Ospedaliera "Bianchi Melacrino Morelli, "Reggio Calabria, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24406DOI Listing
August 2016

Safety and efficacy of ruxolitinib in myelofibrosis patients without splenomegaly.

Br J Haematol 2016 07 28;174(1):160-2. Epub 2015 Oct 28.

Department of Haematology and Oncology, Città della Salute e della Scienza Hospital, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13758DOI Listing
July 2016

Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years.

Am J Hematol 2016 Jun;91(4):E267-72

Institute of Hematology "L. E A. Seràgnoli," Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.24310
Publisher Site
http://dx.doi.org/10.1002/ajh.24310DOI Listing
June 2016

Circulating CD4+CD25-Foxp3+ cells are increased in patients with immune thrombocytopenia.

Immunol Lett 2015 Jul 2;166(1):63-4. Epub 2015 May 2.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imlet.2015.04.006DOI Listing
July 2015

Ruxolitinib-associated tuberculosis: a case of successful ruxolitinib rechallenge.

Ann Hematol 2015 Mar 30;94(3):519-20. Epub 2014 Aug 30.

Institute of Hematology "L. and A. Seràgnoli," St Orsola-Malpighi Hospital, Department of Specialistic, Diagnostic and Experimental Medicine, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2183-0DOI Listing
March 2015

Platelet fluctuations during thrombopoietin-receptor agonist treatment: correlation with platelet apoptosis.

Ann Hematol 2015 Feb 4;94(2):339-41. Epub 2014 Jul 4.

Institute of Hematology "L. and A. Seràgnoli", St Orsola-Malpighi Hospital, Department of Specialistic, Diagnostic and Experimental Medicine, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2156-3DOI Listing
February 2015

The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.

Am J Hematol 2014 Nov 27;89(11):1047-50. Epub 2014 Aug 27.

Institute of Hematology "L. and A. Serágnoli", Department of Experimental, Diagnostic and Specialty Medicine, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23823DOI Listing
November 2014

Definition and treatment of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia.

Expert Rev Hematol 2014 Jun 25;7(3):397-406. Epub 2014 Mar 25.

Department of Hematology and Oncology "L. and A. Seràgnoli", Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2014.900432DOI Listing
June 2014

Treatment recommendations for chronic myeloid leukemia.

Mediterr J Hematol Infect Dis 2014 Jan 2;6(1):e2014005. Epub 2014 Jan 2.

Institute of Hematology "L. and A. Seràgnoli", Department of Specialty, Diagnostic and Experimental Medicine, University of Bologna, S.Orsola-Malpighi University Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2014.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894838PMC
January 2014

Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.

Ann Hematol 2013 Jan 31;92(1):67-78. Epub 2012 Aug 31.

Institute of Hematology, Department of Hematology and Oncological Sciences L. e A. Seràgnoli, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-012-1556-5DOI Listing
January 2013

Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase.

Crit Rev Oncol Hematol 2012 May 11;82(2):159-70. Epub 2011 May 11.

Department of Hematology and Oncology L. and A. Seràgnoli, University of Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2011.04.002DOI Listing
May 2012

Physician's guide to the clinical management of adverse events on nilotinib therapy for the treatment of CML.

Cancer Treat Rev 2012 May 12;38(3):241-8. Epub 2011 Aug 12.

Department of Hematology and Oncology, L. and A. Seràgnoli, St. Orsola University Hospital, University of Bologna, 9-40138 Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2011.07.004DOI Listing
May 2012

Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency.

Hematol Rep 2012 May 26;4(2):e10. Epub 2012 Jun 26.

Department of Hematology and Oncology L. e A. Seràgnoli, St. Orsola-Malpighi Hospital, University of Bologna;

View Article

Download full-text PDF

Source
http://www.pagepress.org/journals/index.php/hr/article/view/
Publisher Site
http://dx.doi.org/10.4081/hr.2012.e10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401131PMC
May 2012

Imatinib in chronic myeloid leukemia elderly patients.

Aging (Albany NY) 2011 Dec;3(12):1125-6

Department of Hematology and Clinical Oncology "Seràgnoli", S.Orsola-Malpighi Hospital, University of Bologna, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273892PMC
http://dx.doi.org/10.18632/aging.100420DOI Listing
December 2011

Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study.

Ann Hematol 2011 Aug 2;90(8):933-8. Epub 2011 Feb 2.

Department of Hematology and Oncology L. e A. Seràgnoli, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00277-010-1154
Web Search
http://link.springer.com/10.1007/s00277-010-1154-3
Publisher Site
http://dx.doi.org/10.1007/s00277-010-1154-3DOI Listing
August 2011

The CD47 pathway is deregulated in human immune thrombocytopenia.

Exp Hematol 2011 Apr 4;39(4):486-94. Epub 2011 Jan 4.

Department of Hematology and Oncological Sciences L. & A. Seràgnoli, Institute of Hematology, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2010.12.011DOI Listing
April 2011

Dasatinib and nilotinib in imatinib-resistant Philadelphia-positive chronic myelogenous leukemia: a 'head-to-head comparison'.

Leuk Lymphoma 2010 Apr;51(4):583-91

Department of Hematology and Oncology L. e A. Seràgnoli, S. Orsola-Malpighi University Hospital, 9-40138 Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428191003637282DOI Listing
April 2010

Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure.

Haematologica 2009 Dec 16;94(12):1758-61. Epub 2009 Jul 16.

Department of Hematology and Medical Oncology L. and A. Seràgnoli, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2009.010496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791949PMC
December 2009

Response definitions and European Leukemianet Management recommendations.

Best Pract Res Clin Haematol 2009 Sep;22(3):331-41

Department of Hematology-Oncology L. and A. Seràgnoli, S.Orsola-Malpighi University Hospital, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2009.10.001DOI Listing
September 2009

Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.

Am J Hematol 2009 Apr;84(4):215-20

Department of Hematology and Medical Oncology L. e A. Seràgnoli, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21360DOI Listing
April 2009

Association of essential thrombocythemia and non-Hodgkin lymphoma: a single-centre experience.

Leuk Lymphoma 2009 Mar;50(3):481-4

Department of Hematology/Oncology, L and A Seragnoli, St Orsola-Malpighi University Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802713521DOI Listing
March 2009

JAK2 V617F mutation in essential thrombocythemia: correlation with clinical characteristics, response to therapy and long-term outcome in a cohort of 275 patients.

Leuk Lymphoma 2009 Feb;50(2):247-53

Department of Hematology and Clinical Oncology L. and A. Seràgnoli, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802688152DOI Listing
February 2009

Management of acute graft versus host disease (GvHD).

Hematol J 2004 ;5(3):189-96

Dipartimento di Emato-Oncologia, Ospedale San Martino, Genova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.thj.6200399DOI Listing
September 2004